OUR RESEARCH SERVICES
Our principal and sub investigators are physicians who are fellowship-trained MDs, double-board certified in Pain Medicine and Anesthesiology. Review Our Services.
PHASE 1-4 CLINICAL TRIALS
We offer Phase I-IV clinical trials providing the all pieces of critical information about the effect of a new drug on humans which is necessary for complete development of a drug/therapy. Once the initial Phase I/II trials are complete, drug development may progress into larger clinical studies that continue to test the safety of the new drug and how well it works in treating a particular disorder.
DEVICE & MEDICATION STUDIES
Our investigational device studies observe medical devices as the subject of our clinical studies designed to evaluate the effectiveness and/or safety of the device.
- Clinical investigations undertaken to develop safety and effectiveness data for medical devices must be conducted according to the requirements of the FDA IDE regulations.
- An approved IDE permits a device that otherwise would be required to comply with a performance standard or to have pre-market approval to be shipped lawfully for the purpose of conducting investigations of that device.
PROTOCOL DEVELOPMENT AND DESIGN
We are able to develop and design a protocol to meet the needs of your company. We have experience taking trials through every step of the research process, including protocol development, IRB application and trial management.
EXPERIMENTAL PAIN STUDIES
Initial efforts focused on developing reliable methods to quantify pain. With aid of these methods, early research successfully addressed longstanding questions of opioid pharmacology such as tolerance, mode and site of action, and drug-related development of hyperalgesia. In addition to a sustained interest in opioid pharmacology, multiple methods were implemented to evaluate efficacy and potential clinical utility of novel pain therapeutics and interventions. Today’s studies take advantage of proteomic, genomic, electro-physiological and imaging techniques to delineate new therapeutic pathways, guide clinical development strategies and advance pain therapy.